Bhagwan Dass Pharmaceutical Limited
About Bhagwan Dass Pharmaceutical Limited
Data last updated:
Bhagwan Dass Pharmaceutical Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PLC360532. Its GSTIN is 07AAICB8704D1ZU (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prajwal Arora and Rekha Sareen.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1495 G/F Shankar Niwas Building Niwas Bhagirath Palace, New Delhi, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹74,630, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹4,768 (net margin -6.4%) and EBITDA of -₹4,768 (EBITDA margin -6.4%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
Company details
Contact details
Bhagwan Dass Pharmaceutical Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1495 G/F Shankar Niwas Building Niwas Bhagirath Palace, New Delhi, Delhi, India – 110006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bhagwan Dass Pharmaceutical Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bhagwan Dass Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bhagwan Dass Pharmaceutical Limited, buy the company report.
Financials of Bhagwan Dass Pharmaceutical Limited
FY 2025 filings availableBhagwan Dass Pharmaceutical Limited reported revenue of ₹74,630 (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 11% fall in the latest year. EBITDA fell 160% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4,768 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,768 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.4% | ||||
| Net Profit Margin | -6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bhagwan Dass Pharmaceutical Limited, buy the company report.
Board of directors of Bhagwan Dass Pharmaceutical Limited
Bhagwan Dass Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prajwal Arora | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
| Rekha Sareen | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
| Namrata Arora | Director | 24 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Bhagwan Dass Pharmaceutical Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambar Chemicals Private Limited | ₹75,500 (FY 2023) | -65.0% | Thane, Maharashtra, India | |||
| Arugn Technologies Private Limited | ₹75,500 (FY 2025) | Delhi, India | ||||
| Dilsun Ayurvedic and Herbal Products Private Limited | ₹75,000 (FY 2020) | -91.0% | Purnia, Bihar, India | |||
| Inventive Chemical Private Limited | ₹74,983 (FY 2025) | 178.0% | Noida, Uttar Pradesh, India | |||
| Hariayu Herbal (OPC) Private Limited | ₹74,919 (FY 2025) | Shujalpur, Madhya Pradesh, India | ||||
| Bhagwan Dass Pharmaceutical Limitedthis company | ₹74,630 (FY 2025) | -₹4,768 | -6.4% | -11.0% | New Delhi, Delhi, India | |
| TVR Pharmaceuticals Private Limited | ₹74,470 (FY 2024) | Hyderabad, Telangana, India | ||||
| A. V. Surgicure Private Limited | ₹74,260 (FY 2025) | -13.0% | Ahmedabad, Gujarat, India | |||
| Lionet Expocom Private Limited | ₹74,121 (FY 2024) | -99.0% | Ahmedabad, Gujarat, India | |||
| Shree Laxmi Narain Chemical Products India Pvt Ltd | ₹73,753 (FY 2025) | 13.0% | Delhi, India | |||
| Ramkrishna Ayushveda Private Limited | ₹73,632 (FY 2025) | 9.0% | Ichalkaranji, Maharashtra, India |
To see the full peer comparison of Bhagwan Dass Pharmaceutical Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bhagwan Dass Pharmaceutical Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bhagwan Dass Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bhagwan Dass Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICB8704D1ZU | Delhi | Active | 26 Mar 2020 |
To see the full GST registrations and return filing status of Bhagwan Dass Pharmaceutical Limited, buy the company report.
Recent activity
Bhagwan Dass Pharmaceutical Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Namrata Arora was appointed as Director on 24 Aug 2024.
Frequently asked questions
Bhagwan Dass Pharmaceutical is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 January 2020 (6+ years old) and is registered under CIN U24304DL2020PLC360532.
Bhagwan Dass Pharmaceutical has 3 current directors:
- Prajwal Arora - Director
- Rekha Sareen - Director
- Namrata Arora - Director
The latest financial statements of Bhagwan Dass Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bhagwan Dass Pharmaceutical is 07AAICB8704D1ZU, registered in Delhi.
The CIN (Corporate Identification Number) of Bhagwan Dass Pharmaceutical is U24304DL2020PLC360532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bhagwan Dass Pharmaceutical was incorporated on 21 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bhagwan Dass Pharmaceutical by revenue are Ambar Chemicals Private Limited, Arugn Technologies Private Limited, Dilsun Ayurvedic and Herbal Products Private Limited, Inventive Chemical Private Limited, Hariayu Herbal (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Namrata Arora was appointed as Director on 24 Aug 2024. Praveen Kumar ceased to be Director on 24 Aug 2024. Prajwal Arora was appointed as Director on 21 Jan 2020. Bhagwan Dass Pharmaceutical has 4 board changes on record in total.
The registered office of Bhagwan Dass Pharmaceutical is at 1495 GF Shankar Niwas Building Niwas Bhagirath Palace, New Delhi, Delhi, India – 110006.
Bhagwan Dass Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Bhagwan Dass Pharmaceutical can be reached at its registered office: 1495 GF Shankar Niwas Building Niwas Bhagirath Palace, New Delhi, Delhi, India – 110006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
